Literature DB >> 1325318

Measurement of plasma volume in pregnancy.

M A Brown1, D A Mitar, J A Whitworth.   

Abstract

1. Determination of the plasma volume in pregnant women is a useful research tool and may become an important clinical measurement. We used three methods to determine plasma volume using Evans Blue dye: (1) the 'usual' method, measuring serum absorbance at a wavelength of 610 nm, (2) a two-wavelength method, and (3) precipitation of non-albumin proteins by the addition of polyethyleneglycol before measuring serum absorbance at a wave-length of 620 nm. These were each compared with the standard 125I-human serum albumin method in 20 non-pregnant subjects. Subsequently, the polyethylene glycol method was considered the standard and the three Evans Blue dye methods were compared in 20 pregnant women. 2. In non-pregnant subjects mean plasma volumes did not differ significantly according to the method used. However, the limits of agreement with 125I-human serum albumin method were closest for the polyethyleneglycol method, for both clear and turbid sera. 3. In pregnant women, mean plasma volume values did not differ according to the Evans Blue dye method used, but the limits of agreement were significantly closer with the two-wavelength method than with the 'usual' method (P less than 0.05) largely owing to the effects of turbid sera. 4. These studies demonstrate that considerable error may occur when the Evans Blue dye concentration is determined in turbid sera by the 'usual' method. This can be overcome by the use of the two-wavelength method or the polyethyleneglycol method. The most accurate results will be obtained if the latter method is employed routinely to determine plasma volume in pregnant women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325318     DOI: 10.1042/cs0830029

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability.

Authors:  P W Hamer; J M McGeachie; M J Davies; M D Grounds
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

2.  Albumin Binds Doxorubicin via Self-Assembling Dyes as Specific Polymolecular Ligands.

Authors:  Anna Jagusiak; Katarzyna Chłopaś; Grzegorz Zemanek; Izabela Kościk; Paweł Skorek; Barbara Stopa
Journal:  Int J Mol Sci       Date:  2022-05-01       Impact factor: 6.208

3.  Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients.

Authors:  M Giordano; P Lucidi; T Ciarambino; L Gesuè; P Castellino; M Cioffi; P Gresele; G Paolisso; P De Feo
Journal:  Diabetologia       Date:  2007-11-17       Impact factor: 10.122

4.  Evans blue-mediated white-light detection of non-muscle-invasive bladder cancer: A preclinical feasibility and safety study using a rat bladder urothelial cell carcinoma model.

Authors:  Sanne Elsen; Evelyne Lerut; Frank Van Der Aa; Ben Van Cleynenbreugel; Hendrik Van Poppel; Peter De Witte
Journal:  Mol Clin Oncol       Date:  2016-10-04

5.  Interaction of Supramolecular Congo Red and Congo Red-Doxorubicin Complexes with Proteins for Drug Carrier Design.

Authors:  Anna Jagusiak; Katarzyna Chłopaś; Grzegorz Zemanek; Izabela Kościk; Irena Roterman
Journal:  Pharmaceutics       Date:  2021-11-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.